Eterna Therapeutics Inc. (ERNA)
NASDAQ · Healthcare
Eterna Therapeutics Inc. Long Term Debt 2010–2024
Eterna Therapeutics Inc. annual/quarterly long term debt history from 2013 to 2020. Long term debt refers to financial obligations that are due more than one year in the future.
- Eterna Therapeutics Inc. long term debt for the quarter ending December 31, 2020 were 532,000, a 85.81% decrease year-over-year.
- Eterna Therapeutics Inc. long term debt for 2020 were 532,000, a 85.81% decrease from 2018.
- Eterna Therapeutics Inc. long term debt for 2018 were 3.8M, a 26.80% decrease from 2017.
- Eterna Therapeutics Inc. long term debt for 2017 were 5.1M, a 36.84% decrease from 2016.
- Eterna Therapeutics Inc. long term debt for 2016 were 8.1M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Eterna Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2020 | $1 |
| 2018 | $4 |
| 2017 | $5 |
| 2016 | $8 |
| 2015 | $7 |
| 2014 | $5 |
| 2013 | $2 |
| Eterna Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2020-12-31 | $1 |
| 2018-12-31 | $4 |
| 2017-12-31 | $5 |
| 2016-12-31 | $8 |
| 2015-12-31 | $7 |
| 2014-12-31 | $5 |
| 2013-12-31 | $2 |
Eterna Therapeutics Inc. Long Term Debt — FAQ
Eterna Therapeutics Inc. (ERNA) long term debt over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ERNA's long term debt history?
The chart and table above show Eterna Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.